AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cheryl Galt who wrote (655)	9/3/1997 2:15:00 PM
From: Jim Lovejoy	of 2173

>I too follow multiple threads, and would appreciate the reduced redundancy >your suggestion would provide. In fact, I propose EXTENDING your concept. >The thread could be called "Drugs for Diabetes and Obesity --- Competition >and Synergy" A great idea, but I think it still doesn't go far enough. I would like to extend the title to include "Drugs and Devices for Diabetics and Obesity --- Competition and Synergy." The reason is that there are several devices such as those that would make it posible to inhale insulin, (See Inhale & ARADIGM), And others that would involve non-invasive glucose reading. These devices also have Competitive & Synergic effects with the insulin therapy drugs (an example, some of the news releases on AMLN mentioned that it was effective mixed with insulin, if that insuling can be inhaled, the market for AMLN may well go up.) BTW, I think the suggestion that other threads be referenced by links, a good one. JL

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next